Apr 11, 2013 by Dan CarrollWhy the Dow's Tech Stocks Met the Blue Screen of DeathMarkets rise again, but falling PC sales send Microsoft and HP crashing into the red.
Apr 10, 2013 by Dan CarrollToday's 3 Worst StocksRetail, solar energy, and refining cap today's losers.
Apr 10, 2013 by Dan CarrollThe Best Dow Stock Everyone's SellingCaterpillar has been crushed by slowing sales growth, but is this the best time to buy this sturdy stock for cheap?
Apr 10, 2013 by Dan CarrollQE Optimism Pushes the Dow to Triple-Digit GainsThere's no end in sight for the stimulus after the Fed releases its minutes.
Apr 9, 2013 by Dan CarrollIntel and Microsoft Electrify a Record-Setting DowMarkets advance on new highs as tech stocks surge.
Apr 8, 2013 by Dan CarrollManchester United, Aon Ink Eight-Year PartnershipCompanies agree on training center naming rights and to extend previous business relationship.
Apr 8, 2013 by Dan CarrollEarnings Bring Hope for Alcoa's Troubled Stock Despite a revenue miss, signs of optimism emerge for this downbeat aluminum producer
Apr 8, 2013 by Dan CarrollRoche, Isis Pharmaceuticals to Develop Huntington's Disease TreatmentsCompanies agree to an alliance to find therapies for the brain disorder
Apr 8, 2013 by Dan Carroll"Evil Dead" Tops Weekend Box OfficeSony's horror picture beat out competition from Paramount and 20th Century Fox
Apr 8, 2013 by Dan CarrollAll Eyes on Alcoa as the Dow Kicks Off Earnings SeasonThe blue-chip index stalls as investors stay cautious ahead of Alcoa's quarterly report.
Apr 8, 2013 by Dan CarrollAbbott Labs: Too Cheap to Ignore?Here's a classic case of how relying on the P/E ratio can deceive investors.
Apr 7, 2013 by Dan CarrollThe Dow Kicks Off Earnings Season: What Should You Expect?Alcoa and JPMorgan Chase are on tap to release results in the upcoming week
Apr 7, 2013 by Dan CarrollJohnson & Johnson's Biggest Drug RivalsWe take a look into the competitors of J&J's top-selling drugs
Apr 6, 2013 by Dan CarrollIs America Cheap Enough for Your Portfolio?U.S. markets have surged in 2013, but how does the average American stock valuation compare with other leading nations' markets?
Apr 6, 2013 by Dan CarrollAstraZeneca's Arthritis Drug Succeeds in Phase 3 TrialFostamatinib pulled down top-line results in a rheumatoid arthritis study of its effectiveness and safety.
Apr 6, 2013 by Dan CarrollBiogen Hits Primary Endpoints in MS StudyCompany's phase 2b trial of daclizumab succeeds in efficacy.
Apr 5, 2013 by Dan CarrollJapan's Stimulus Opens the Yen FloodgatesThe Nikkei rises more than 3% during the week, as financial stocks surge
Apr 5, 2013 by Dan CarrollFalling Jobs Growth Leads to a Plunging DowStocks decline sharply on the heels of a disappointing jobs report.
Apr 5, 2013 by Dan CarrollAbbott and Ache Labs: A Perfect Match?After spinning off its pharmaceuticals business, should Abbott buy this Brazilian pharmaceutical firm?
Apr 4, 2013 by Dan CarrollBoeing Opens Expanded Airplane Delivery CenterNew facility in Everett, Washington will deliver 777s and 787s, among other craft.
